Leidse hoogleraren vanaf 1575

Adam Frederik Cohen (Adam)

Geboren
1952-11-08 te Haarlem, Nederland
Geslacht
Man

Promotie (1986)

Type examen
Promotie
Datum
1986-05-29
Plaats
Leiden
Proefschrift
The human pharmacology of acrivastine and lamotrigine

Aanstelling

Faculteit
Geneeskunde
Vakgebied
Farmacologie
Leeropdracht
Klinische farmacologie
Datum oratie
1995-03-31
Titel oratie
Klinische farmacologie- tussen middel en kwaal

Publicaties

Wetenschappelijk
  • Kanhai K.M.S., Goulooze S.C., Stevens J., Hay J.L., Dent G., Verma A., Hankemeier T., Boer T. de, Meijering H., Chavez J.C., Cohen A.F. & Groeneveld G.J. (2016), Quantifying Beta‚ÄźGalactosylceramide Kinetics in Cerebrospinal Fluid of Healthy Subjects Using Deuterium Labeling, Clinical and translational Science 9(6): 321-327.
  • Goulooze S.C., Cohen A.F. & Rissmann R. (2016), Olaparib., British Journal of Clinical Pharmacology 81(1): 171-173.
  • Goulooze S.C., Cohen A.F. & Rissmann R. (2015), Mirabegron, British Journal of Clinical Pharmacology 80(4): 762-764.
  • Goulooze S.C., Cohen A.F. & Rissmann R. (2015), Lomitapide, British Journal of Clinical Pharmacology 80(2): 179-181.
  • Goulooze S.C., Cohen A.F. & Rissmann R (2015), Bedaquiline, British Journal of Clinical Pharmacology 80(2): 182-184.
  • Zuurman L., Roy C., Schoemaker R.C., Hazekamp A., Den Hartigh J., Bender J.C.M.E., Verpoorte R., Pinquier J., Cohen A.F. & Gerven J.M.A. van (2008), Effect of intrapulmonary tetrahydrocannabinol administration in humans, Journal of Psychopharmacology 22: 707-716.
  • Jacobs G.E. & Cohen A.F. (2008), The South London and Maudsley NHS Foundation Trust and Oxleas NHS Foundation Trust Prescribing Guidelines, 9th edition, British Journal of Clinical Pharmacology.
  • Haas S. de, Dingemanse J., Hoever P., Cohen A.F. & Gerven J.M.A. van (2007), Pseudo-hallucinations after zolpidem intake: A case report, Journal of Clinical Psychopharmacology 27: 728-730.
  • Haas S.L.. de, Visser S.J. de, Post J.P. van der, Smet M. de, Schoemaker R.C., Rijnbeek B., Cohen A.F., Vega J.M., Agrawal N.G.B., Goel T.V., Simpson R.C., Pearson L.K., Li S., Hesney M., Murphy M.G. & Gerven J.M.A. van (2007), Pharmacodynamic and pharmacokinetic effects of TPA023, a GABAA a2,3 subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers., Journal of Psychopharmacology 21: 374-383.
  • Boot J.D., Haas S. de, Tarasevych S., Roy C., Wang L., Amin D., Cohen J., Sterk P.J., Miller B., Paccaly A., Burggraaf J., Cohen A.F. & Diamant Z. (2007), Effect of an NK1/NK2 receptor antagonist on airway responses and inflammation to allergen in asthma, American Journal of Respiratory and Critical Care Medicine 175(5): 450-457.
  • Haas S. de, Otte A., Weerd A. de, Erp G van, Cohen A.F. & Gerven J.M.A. van (2007), Exploratory polysomnographic evaluation of pregabalin on sleep disturbance in patients with epilepsy, Journal of clinical sleep medicine 3: 473-478.
  • Doorn M. van, Vogels J., Tas A., Hoogdalem E.J. van, Burggraaf J., Cohen A.F. & Greef J. van der (2007), Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers, British Journal of Clinical Pharmacology 63(5): 562-574.
  • Post J.P. van der, Visser S.J. de, Kam M.L. de, Woelfler M., Hilt D.C., Vornov J., Burak E.S., Bortey E., Slusher B.S., Limsakun T., Cohen A.F. & Gerven J.M.A. van (2005), The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693., British Journal of Clinical Pharmacology 60: 128-136.
  • Boot J.D., Tarasevych S., Sterk P.J., Schoemaker R.C., Wang L., Amin D., Cohen A.F. & Diamant Z. (2005), Reversal of the late asthmatic response increases exhaled nitric oxide, Respiratory Medicine 99: 1591-1594.
  • Dumont G.J.H., Visser S.J. de, Cohen A.F. & Gerven J.M.A. van (2005), Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy volunteers., British Journal of Clinical Pharmacology 59: 495-510.
  • Dumont G.J.H., Visser S.J. de, Cohen A.F. & Gerven J.M.A. van (2005), Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects, British Journal of Clinical Pharmacology 59: 495-510.
  • Cohen J., Burggraaf J., Schoemaker R.C., Sterk P.J., Cohen A.F. & Diamant Z. (2005), Relationship between airway responsiveness to neurokinin A and methacholine in asthma, Pulmonary Pharmacology and Therapeutics 17: 171-176.
Vakpublicaties
  • Bronswijk H. van, Dubois E.A., Zitman F.G. & Cohen A.F. (2007), New drugs; varenicline, Nederlands Tijdschrift voor Geneeskunde 151: 2503-2504.
Overig
  • Miley G.K., Carilli C. L., Taylor E.N., De Breuck C. & Cohen A.F. (2009), High Redshift Radio Galaxies: Laboratories for Massive Galaxy and Cluster Formation in the early Universe. [overig]
  • Haas S.L.. de, Visser S.J. de, Kam M.L. de, Smet M. de, Murphy G., Vessey L., Cohen A.F. & Gerven J.M.A. van (2007), The selective central nervous system (CNS) effects of two different GABA-A Alpha 2,3 subtype selective agonists compared to lorazepam, Clinical Pharmacology & Therapeutics 81(S63).
  • Zuurman L., Roy C., Asset G., Amatsaleh A., Guimaraes L., Pinquier J., Cohen A.F. & Gerven J.M.A. van (2007), The effects of the novel CB1 antagonist AVE1625 on the THC-induced changes on central nervous system effects and heart rate, Clinical Pharmacology & Therapeutics 81(suppl 1:S4).
  • Zuurman L., Passier P.C., Kam M. de, Kleijn H.J., Cohen A.F. & Gerven J.M.A. van (2007), Pharmacokinetic and pharmacodynamic effects of the intravenously administered CB1 receptor agonist Org 28611 in healthy male volunteers, Clinical Pharmacology & Therapeutics 81(S12).
  • zoethout R.W.M., Haas S.L.. de, Duck K. van, Semt M. de, Rosen L.B., Murphy M.G., Gottesdiener K.M., Schoemaker R.C., Cohen A.F. & Gerven J.M.A. van (2007), A double-blind, double-dummy, randomized, placebo-controlled, crossover study to investigate the effects of ethanol and TPA023 on essential tremor, Basic & Clinical Pharmacology & Toxicology 101(Suppl 1): 91-92.
  • Liem-Moolenaar M., Dunn M., Visser S.J. de, Schoemaker R.C., Cohen A.F., Bye A., Lowy M., Gray F. & Gerven J.M.A. van (2007), Psychomotor and cognitive effects of a single dose of SB223412 in healthy volunteers compared to placebo or haloperidol, Basic & Clinical Pharmacology & Toxicology 101(Suppl 1): 106.

Links

Link naar deze pagina
http://hoogleraren.leidenuniv.nl/id/3442

¬©2015 Universitaire Bibliotheken Leiden www.bibliotheek.leidenuniv.nl